Chroma Medicine is pioneering epigenome editing, a next-generation approach that silences or activates genes without cutting DNA. By modifying the epigenetic marks (methylation, acetylation) that control gene expression, Chroma's approach avoids the permanent DNA changes and safety risks of traditional CRISPR cutting, while maintaining durable therapeutic effects.